The FDA has recently announced a proposal to amend the current Investigational New Drug (IND) application regulations. The proposal involves 2 exemptions for clinical investigations involving lawfully marketed foods (including […] Read More >>
You have probably heard of the terms IND and NDA being used during drug development and applications. People tend to get confused between the two terms and wonder how they […] Read More >>
By Arwen Brooks Quality Assurance & Regulatory Affairs Assistant With the explosion of the natural health product and functional food industry, and the subsequent rules and regulations that have been […] Read More >>